TM Capital is a leading member of Oaklins, the world’s premier middle-market investment banking organization.  Established in 1985 as M&A International and re-branded as Oaklins in 2016, Oaklins offers the unparalleled global resources of over 700 M&A professionals operating in the major financial centers of the world. Oaklins is the collective trade name of independent, industry-leading advisory firms with deep transactional experience, specialized industry expertise, entrenched local relationships and a culture of collaboration and achievement.  Working together, Oaklins professionals have the resources to efficiently access the most likely potential international buyers or investors, as well as a global roster of acquisition targets.  The Oaklins team has closed over 1,500 transactions totaling more than $75 billion in transaction value in the past five years.

TM Capital has been a leading member of Oaklins (and its predecessor, M&A International) since 1994, with nearly one third of TM Capital’s completed transactions having had a cross-border component.

Client Advantages as an Oaklins member firm include:
  • The market reach of a worldwide top 20 M&A advisor
  • Direct relationships with key strategic buyers and financial sponsors around the world
  • Partner-level relationships developed over two decades of collaboration
  • Knowledge of local business customs and access to local experts in accounting, legal, tax, and compliance standards, assuring a smooth cross-border execution


Representative Transactions

  • February 2017

    Uncle Wally’s Acquired by Give & Go

    TM Capital served as exclusive financial advisor to Uncle Wally’s in its sale to Give & Go, a portfolio company of Thomas H. Lee Partners

  • April 2015 | Japan

    NRI Acquires Brierley+Partners

    TM Capital served as exclusive financial advisor to Nomura Research Institute, a $3 billion global IT solutions and consulting services provider based in Tokyo, in its acquisition of Brierley+Partners

  • Ireland

    Sapheon Acquired by Covidien plc

    TM Capital served as exclusive financial advisor to Sapheon Inc., a developer of venous disease treatments, in its sale to Covidien plc, a world leader in the treatment of peripheral vascular disease, for up to $238 million in cash and contingent consideration

  • Denmark

    Bloomingville Acquired by Creative Co-Op

    TM Capital, together with our M&A International partner Audon of Denmark, advised Bloomingville A/S in its sale to Creative Co-Op Inc.

  • United Kingdom

    Acxiom Divests 2Touch to Parseq

    TM Capital, together with our M&A International partner Cavendish Corporate Finance of the UK, negotiated the cross-border divestiture by Acxiom Corporation (NASDAQ: ACXM) of 2Touch Ltd. to UK-based Parseq

  • United Kingdom

    Eschmann Acquired by STERIS

    TM Capital, together with our M&A International partner IBI Corporate Finance of Ireland, advised Eschmann Holdings Limited on its sale to STERIS Corporation (NYSE: STE)

  • Canada

    CHS Acquired by Cortec Group

    TM Capital served as exclusive financial advisor to Canadian Hospital Specialties (“CHS”) in its sale to Cortec Group, a private equity firm with more than $1 billion of capital under management

  • Canada

    Bauer Acquires Inaria International

    TM Capital advised Bauer Performance Sports Ltd. (TSX:BAU), a leading consumer branded provider of hockey and lacrosse athletic equipment, in its acquisition of Inaria International

  • Netherlands

    BWise B.V. Acquired by NASDAQ OMX

    TM Capital advised BWise B.V., a leading Netherlands-based compliance and risk management software provider, in its sale to The NASDAQ OMX (NASDAQ: NDAQ)